Direxion Daily S&P Biotech Bull 3X ETF
LABU
22 hedge funds and large institutions have $40.7M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
83% more capital invested
Capital invested by funds: $22.2M → $40.7M (+$18.5M)
5% more funds holding
Funds holding: 21 → 22 (+1)
3% more call options, than puts
Call options by funds: $66M | Put options by funds: $64M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.11% less ownership
Funds ownership: 5.26% → 5.15% (-0.11%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5M |
| 2 |
Morgan Stanley
New York
|
+$3.87M |
| 3 |
HF
HRT Financial
New York
|
+$2.8M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.62M |
| 5 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$546K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$4.46M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.14M |
| 3 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
-$1.12M |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$815K |
| 5 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$621K |
LABU Hedge Fund Activity: Q4 2019 in Review
22 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2019, worth a combined $40.7M — up 83% from $22.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LABU positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $5M. The largest seller was Citigroup, cutting an estimated $4.46M.
- 22 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2019, up from 21 in Q3 2019.
- Funds reported $40.7M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2019, up 83% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2019 and 3 closed out, a net change of +3 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2019 was Susquehanna International Group, an estimated $5M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2019 was Citigroup, an estimated $4.46M sold.
Based on aggregated 13F filings for Q4 2019.